BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21088425)

  • 1. Non-sentinel lymph node status and prognosis of breast cancer patients with micrometastatic sentinel lymph nodes.
    Onishi T; Jinno H; Takahashi M; Hayashida T; Sakata M; Nakahara T; Shigematsu N; Mukai M; Kitagawa Y
    Eur Surg Res; 2010; 45(3-4):344-9. PubMed ID: 21088425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of sentinel lymph node (SLN) status in primary breast cancer by prospective use of immunohistochemistry increases the rate of micrometastases and isolated tumour cells: analysis of 174 patients after SLN biopsy.
    Rydén L; Chebil G; Sjöström L; Pawlowski R; Jönsson PE
    Eur J Surg Oncol; 2007 Feb; 33(1):33-8. PubMed ID: 17174513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment?
    Port ER; Patil S; Stempel M; Morrow M; Cody HS
    Cancer; 2010 Apr; 116(8):1987-91. PubMed ID: 20151427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary lymph node dissection can be avoided in women with breast cancer with intraoperative, false-negative sentinel lymph node biopsies.
    Takei H; Kurosumi M; Yoshida T; Ishikawa Y; Hayashi Y; Ninomiya J; Tozuka K; Oba H; Inoue K; Nagai S; Saito Y; Kazumoto T; Saitoh J; Tabei T
    Breast Cancer; 2010; 17(1):9-16. PubMed ID: 19701679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the likelihood of additional nodal metastases in breast carcinoma patients with positive sentinel node biopsy.
    Mustać E; Matusan-Ilijas K; Marijić B; Smokvina M; Jonjić N
    Int J Surg Pathol; 2010 Feb; 18(1):36-41. PubMed ID: 19448065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal risk of macrometastases in the non-sentinel axillary lymph nodes in breast cancer patients with micrometastatic sentinel lymph nodes and preoperatively ultrasonically uninvolved axillary lymph nodes.
    Zgajnar J; Besic N; Podkrajsek M; Hertl K; Frkovic-Grazio S; Hocevar M
    Eur J Cancer; 2005 Jan; 41(2):244-8. PubMed ID: 15661549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of sentinel lymph node micrometastases in human breast cancer.
    Cox CE; Kiluk JV; Riker AI; Cox JM; Allred N; Ramos DC; Dupont EL; Vrcel V; Diaz N; Boulware D
    J Am Coll Surg; 2008 Feb; 206(2):261-8. PubMed ID: 18222378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.
    Reed J; Rosman M; Verbanac KM; Mannie A; Cheng Z; Tafra L
    J Am Coll Surg; 2009 Mar; 208(3):333-40. PubMed ID: 19317993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of completion axillary lymph node dissection in patients with immunohistochemical metastases to the sentinel lymph node in breast cancer.
    Pugliese MS; Karam AK; Hsu M; Stempel MM; Patil SM; Ho AY; Traina TA; Van Zee KJ; Cody HS; Morrow M; Gemignani ML
    Ann Surg Oncol; 2010 Apr; 17(4):1063-8. PubMed ID: 20033325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of sentinel node tumor burden on non-sentinel node status and recurrence rates in breast cancer.
    Fan YG; Tan YY; Wu CT; Treseler P; Lu Y; Chan CW; Hwang S; Ewing C; Esserman L; Morita E; Leong SP
    Ann Surg Oncol; 2005 Sep; 12(9):705-11. PubMed ID: 16079953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Completion axillary lymph node dissection not required for regional control in patients with breast cancer who have micrometastases in a sentinel node.
    Yegiyants S; Romero LM; Haigh PI; DiFronzo LA
    Arch Surg; 2010 Jun; 145(6):564-9. PubMed ID: 20566977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors to assess non-sentinel lymph node status in breast cancer patients with sentinel lymph node metastasis.
    Jinno H; Sakata M; Asaga S; Wada M; Shimada T; Kitagawa Y; Suzuki T; Nakahara T; Kitamura N; Kubo A; Mukai M; Ikeda T; Kitajima M
    Breast J; 2008; 14(6):551-5. PubMed ID: 19000054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
    Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
    J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node biopsy in patients with previous ipsilateral complete axillary lymph node dissection.
    Kaur P; Kiluk JV; Meade T; Ramos D; Koeppel W; Jara J; King J; Cox CE
    Ann Surg Oncol; 2011 Mar; 18(3):727-32. PubMed ID: 20593244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND.
    Goyal A; Newcombe RG; Chhabra A; Mansel RE
    Ann Surg Oncol; 2008 Jan; 15(1):262-7. PubMed ID: 17879117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of non-sentinel lymph node metastasis in breast cancer patients.
    Goyal A; Douglas-Jones A; Newcombe RG; Mansel RE;
    Eur J Cancer; 2004 Jul; 40(11):1731-7. PubMed ID: 15251163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.